Treatment of neonate foals with meloxicam

摘要

A method of administering meloxicam containing compositions to neonate foals of 6 weeks of age or less is provided. The inventors have discovered that foals of 6 weeks of age or less can have meloxicam administered at a dosage of 0.6 mg/kg without any negative or adverse reaction by the foal. The method also provides a dosing regimen for obtaining first peak plasma concentrations of approximately 800ng/ml, average plasma concentration levels of 200ng/ml for 6 hours after a single dose, and sustained plasma concentration levels of 100ng/ml with twice daily dosing.